Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-10,562
Closed -$296K 1209
2016
Q4
$296K Sell
10,562
-25,913
-71% -$726K 0.3% 91
2016
Q3
$1M Buy
+36,475
New +$1M 0.55% 42
2016
Q2
Sell
-2,875
Closed -$64K 738
2016
Q1
$64K Buy
+2,875
New +$64K 0.12% 134
2015
Q4
Sell
-244
Closed -$6K 545
2015
Q3
$6K Buy
+244
New +$6K 0.01% 114
2015
Q1
Sell
-4,503
Closed -$106K 594
2014
Q4
$106K Buy
+4,503
New +$106K 0.1% 309

Other funds holding QGENF

Point72 Hong Kong's QGENF Position: Q1 2017 in Review

Point72 Hong Kong sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 10,562 shares — an estimated $296K sold.

Point72 Hong Kong first reported a position in QGENF in Q4 2014 and held it in 5 quarters. The position peaked at $1M in Q3 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Point72 Hong Kong reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Point72 Hong Kong sold 10,562 QIAGEN NV shares in Q1 2017, an estimated $296K.
  • Point72 Hong Kong first reported a position in QIAGEN NV in Q4 2014 and held it in 5 quarters.
  • Point72 Hong Kong's QIAGEN NV position peaked at $1M in Q3 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Point72 Hong Kong's 13F filing for Q1 2017, filed 15 May 2017.